A new study reports a protein called OSMR is required for glioblastoma brain cancer to form.
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
